Literature DB >> 19816748

Radiofrequency ablation of Barrett's esophagus.

Thomas J Watson1.   

Abstract

INTRODUCTION: Barrett's esophagus (BE) is known to be due to chronic gastroesophageal reflux disease and is a precursor of esophageal adenocarcinoma. DISCUSSION: The ability to eliminate BE is appealing, given the neoplastic potential of this condition and the continued increase in incidence of adenocarcinoma involving the esophagus and esophagogastric junction, a highly lethal disease. While a number of endoscopic technologies targeting metaplastic or neoplastic esophageal mucosa have been introduced into the clinical marketplace, most have not been widely adopted. Radiofrequency ablation recently was developed and holds appeal as a reliable, minimally invasive, inexpensive, and well-tolerated technique to destroy pathologic esophageal epithelium.
CONCLUSION: The available data show its efficacy and safety in the short-term, though more mature follow-up is needed to demonstrate its durability in the long-term and its cost-effectiveness in ultimately saving lives.

Entities:  

Mesh:

Year:  2009        PMID: 19816748     DOI: 10.1007/s11605-009-1012-6

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  1 in total

Review 1.  Endoscopic management of Barrett's esophagus: advances in endoscopic techniques.

Authors:  Ali Azarm; Ismet Lukolic; Meenal Shukla; Ronald Concha-Parra; Frank Gress
Journal:  Dig Dis Sci       Date:  2012-07-04       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.